Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV
about
Bioactive natural products with anti-herpes simplex virus properties.Treatment of perinatal viral infections to improve neurologic outcomes.The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.The neonatal anti-viral response fails to control measles virus spread in neurons despite interferon-gamma expression and a Th1-like cytokine profile.Energy Demands of Early Life Drive a Disease Tolerant Phenotype and Dictate Outcome in Neonatal Bacterial Sepsis
P2860
Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@ast
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@en
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@nl
type
label
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@ast
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@en
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@nl
prefLabel
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@ast
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@en
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@nl
P2093
P2860
P356
P1433
P1476
Herpes simplex virus serotype ...... a mouse model of neonatal HSV
@en
P2093
Douglas R Wilcox
Hantamalala R Ranaivo
Mark S Wainwright
Sarah J Kopp
P2860
P2888
P304
P356
10.1038/PR.2014.135
P407
P577
2014-09-08T00:00:00Z
P5875
P6179
1025074144